Skip to main content
. Author manuscript; available in PMC: 2014 Sep 11.
Published in final edited form as: Nanomedicine (Lond). 2013 Aug 1;9(9):1341–1352. doi: 10.2217/nnm.13.92

Figure 2. Measuring the concentration-dependent relaxivity of small magnetite antiretroviral therapy.

Figure 2

(A) In phosphate-buffered saline and (B) monocyte-derived macrophages (MDMs). MDMs were incubated with 100 μM small magnetite antiretroviral therapy (based on ATV content) for 24 h. Collected MDMs and small magnetite antiretroviral therapy were suspended in 1% agar gel. T2 was measured by MRI and magnetite content by inductively coupled mass spectrometry.

R2: Relaxivity; R2: Linear regression coefficient squared.